Tandem Diabetes Care, Inc.
TNDM
$10.99
$0.171.57%
NASDAQ
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | 2.67% | -17.06% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 2.67% | -17.06% | |||
Cost of Revenue | -1.03% | -7.33% | |||
Gross Profit | 6.29% | -24.80% | |||
SG&A Expenses | 4.41% | -0.82% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 1.35% | -5.05% | |||
Operating Income | 7.64% | -5,826.80% | |||
Income Before Tax | 52.72% | -763,156.25% | |||
Income Tax Expenses | -162.86% | 1,245.74% | |||
Earnings from Continuing Operations | 59.86% | -17,392.19% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 59.86% | -17,392.19% | |||
EBIT | 7.64% | -5,826.80% | |||
EBITDA | 8.92% | -924.00% | |||
EPS Basic | 60.25% | -17,346.49% | |||
Normalized Basic EPS | -4.76% | -1,859.69% | |||
EPS Diluted | 60.25% | -17,346.49% | |||
Normalized Diluted EPS | -4.76% | -1,868.95% | |||
Average Basic Shares Outstanding | 0.97% | 0.71% | |||
Average Diluted Shares Outstanding | 0.97% | 0.37% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |